The congress had an intensive programme composed by different types of sessions. It began with medical workshops of level 1, 2 and 3 of the ‘A Project’, granting an African Certificate for PID Diagnosis and Management, and with a ‘Biological A Project’ on how flowcytometry can help in PID diagnosis. Both types of workshops were followed by discussion of successfull clinical cases and biological clinical cases’ sessions.
The lectures that followed focused on African PID related specificities like predisposition to bacteria, skin predisposition to viruses, complement deficiencies and autoimmune diseases, arguments for vaccination, and also PIDs revealed in adulthood, which shows the region has made progress in PID diagnosis.
IG therapy supply issues in remote areas
The meeting of IG experts was built around the question ‘What residual dose of IgG for the Maghreb population’. Prof Fethi Mellouli presented the results of a survey from Tunisia and after different lectures and audience comments, the conclusion was that if a minimum level is required, trough levels must be considered as a personal variable as a set value wouldn’t suit all patients. The presentation that followed went over subcutaneous IGs, while still not available in many countries of the region, it could be a way to facilitate home therapy of PID patients. Prof Rachida Boukari, from Algeria, a very large country, had an interesting presentation on the difficulties faced by patients living far from big cities to access replacement treatment. IPOPI provided patient global views on IG therapy, presenting data from the Principles of Care follow up survey that was released this year.
The next ASID-IPOPI-INGID meeting in Africa will take place on April 11-13, 2019, in Dakar, Senegal, under the appealing theme “Think PID in Africa and save lives”.